CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A)

Clinical trials for CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A) explained in plain language.

Never miss a new study

Get alerted when new CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A) trials appear

Sign up with your email to follow new studies for CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major heart study aims to tame a hidden risk factor

Disease control Ongoing

This large, late-stage trial is testing whether a new drug called pelacarsen can reduce the risk of major heart problems like heart attacks and strokes. It involves over 8,300 people who already have heart disease and have high levels of a specific blood fat called lipoprotein(a)…

Matched conditions: CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A)

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A)

Get alerted when new CARDIOVASCULAR DISEASE AND LIPOPROTEIN(A) trials appear

Major heart study aims to tame a hidden risk factor